Nexgel (NXGL) Equity Average (2019 - 2025)
Historic Equity Average for Nexgel (NXGL) over the last 7 years, with Q3 2025 value amounting to $5.3 million.
- Nexgel's Equity Average rose 1175.23% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 1175.23%. This contributed to the annual value of $5.6 million for FY2024, which is 1216.12% down from last year.
- As of Q3 2025, Nexgel's Equity Average stood at $5.3 million, which was up 1175.23% from $5.3 million recorded in Q2 2025.
- Nexgel's 5-year Equity Average high stood at $11.2 million for Q1 2022, and its period low was $376500.0 during Q3 2021.
- In the last 5 years, Nexgel's Equity Average had a median value of $5.7 million in 2023 and averaged $5.7 million.
- In the last 5 years, Nexgel's Equity Average skyrocketed by 272449.44% in 2021 and then crashed by 3304.3% in 2023.
- Over the past 5 years, Nexgel's Equity Average (Quarter) stood at $6.3 million in 2021, then increased by 26.14% to $7.9 million in 2022, then dropped by 27.96% to $5.7 million in 2023, then fell by 3.12% to $5.5 million in 2024, then decreased by 3.93% to $5.3 million in 2025.
- Its last three reported values are $5.3 million in Q3 2025, $5.3 million for Q2 2025, and $5.8 million during Q1 2025.